FDAFDA · Food and drugs·Recall number D-0541-2024
Pregabalin Capsules 50mg, 1000-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, Manufactured by: Laurus Labs Limited, Anakapalli-531011, India, NDC 64980-411-10
Published June 12, 2024 · Recall initiated: May 16, 2024
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign Tablets/Capsules: Complaint received from a re-packager, American Health Packaging (AHP), where a foreign tablet was discovered in one of the bottles during packaging set up. Tablet identified as pantoprazole tablet 20mg.
What to do
Voluntary: Firm initiated
Recall details
- Brand
- PREGABALIN
- Manufacturer
- Rising Pharma Holding, Inc.
- Distributor
- Nationwide in the USA
- UPC
- 0364980413107
- Lot
- Lot: 23132611, Exp 07/31/2026
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.